Abstract
RESULTS:
The positive rate of FHIT expression was significantly lower in gallbladder carcinoma than that in gallbladder adenoma and chronic cholecystitis (47.1% vs 66.7%, 91.7%, P < 0.01), while the positive rate of Ki-67 expression was markedly higher than that in gallbladder adenoma and chronic cholecystitis (82.4% vs 20.0%, 0, P < 0.01). Loss of FHIT expression was significantly correlated with the higher histological grade (18.8% vs 56.5%, 66.7%, P = 0.02) and lymph node or distant metastasis (33.3% vs 66.7%, P = 0.019), as well as survival time after operation (31.2% vs 77.8%, P = 0.041). The expression of Ki-67 was increased with the higher histological grades (58.3% vs 87.0%, 93.8%, P = 0.039) and lymph node or distant metastasis (33.3% vs 66.7%, P = 0.037). There was a negative correlation between FHIT and Ki-67 (r = -0.285, P = 0.043).
CONCLUSION:
FHIT may be a candidate tumor suppressor gene of gallbladder carcinoma. FHIT and Ki-67 play significant roles in the pathogenesis and evolution of gallbladder carcinoma. The combined detection of FHIT and Ki-67 protein may be helpful for clinical assessment of tumor biological behavior and prognosis in patients with gallbladder carcinoma. 
